![Transparency Market Researchが調査・発行した産業分析レポートです。アチパメゾールの世界市場2020-2030：用途別（鎮静、抗毒性[適応外使用]）、投与経路別、動物別、流通チャンネル別 / Atipamezole Market (Application: Anti-sedative and Antitoxic [Off-label Use]; Route of Administration: Intramuscular, Intravenous, and Others; Animal Type: Dogs, Cats, and Others; and Distribution Channel: Veterinary Hospitals, Retail Pharmacies, and Online Pharmacies) - Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030 / TMR2008078資料のイメージです。](https://www.marketresearch.co.jp/images-folder2/report-contents-28.gif) | • レポートコード：TMR2008078 • 出版社/出版日：Transparency Market Research / 2020年6月 • レポート形態：英文、PDF、190ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートではアチパメゾールの世界市場について調査・分析し、序文、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、用途別（鎮静剤、抗毒性（適応外使用））分析、投与経路別（筋肉内、静脈内、その他）分析、動物種類別（犬、猫、その他）分析、流通チャンネル別（獣医病院、小売薬局、オンライン薬局）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを含め、以下の構成でご提供いたします。 ・序文 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・アチパメゾールの世界市場：用途別（鎮静剤、抗毒性（適応外使用）） ・アチパメゾールの世界市場：投与経路別（筋肉内、静脈内、その他） ・アチパメゾールの世界市場：動物種類別（犬、猫、その他） ・アチパメゾールの世界市場：流通チャンネル別（獣医病院、小売薬局、オンライン薬局） ・アチパメゾールの世界市場：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Atipamezole Market – Scope of the Report
TMR’s report on the global atipamezole market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2020 to 2030. The report provides revenue of the global atipamezole market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global atipamezole market during the forecast period.
The report has been prepared after primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global atipamezole market.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global atipamezole market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global atipamezole market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global atipamezole market.
The report delves into the competition landscape of the global atipamezole market. Key players operating in the global atipamezole market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global atipamezole market that have been profiled in this report.
Key Questions Answered in Atipamezole Market Report
What is the scope of growth for product companies in the global atipamezole market?
What will be the Y-o-Y growth of the global atipamezole market between 2020 and 2030?
What is the influence of changing trends in technologies on the global atipamezole market?
Will North America continue to be the most profitable market for atipamezole?
Which factors are anticipated to hamper the growth of the global atipamezole market during the forecast period?
Which are the leading companies in the global atipamezole market?
Research Methodology
A unique methodology has been utilized by TMR to conduct comprehensive research on the growth of the global atipamezole market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary research sources referred to by analysts during the production of the global atipamezole market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the atipamezole market as primary methods.
These primary research respondents have provided exclusive information during interviews, which serves as a validation from the atipamezole market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global atipamezole market with accuracy. The study also uses the top-down approach to assess the revenues of each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global atipamezole more reliably and accurately.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Atipamezole Mark
4. Market Overview
4.1. Introduction
4.1.1. Application/Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Increase in number of pet ownership and pet adoption
4.3.1.2. Rise in health care expenditure on animals
4.3.1.3. Increase in awareness about veterinary care
4.3.2. Restraints
4.3.2.1. Side-effects of atipamezole
4.3.2.2. Stringent government regulations
4.3.3. Opportunities
4.3.3.1. Research & Development
4.3.3.2. Expansion in Emerging Market
4.4. Global Atipamezole Market Analysis and Forecast, 2018–2030
5. Key Insights
5.1. Regulatory Scenario
5.2. Number of Animals, by Country/Sub-region
5.3. Overview of Veterinary Care
6. Global Atipamezole Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Atipamezole Market Value Forecast, by Application, 2018–2030
6.3.1. Anti-sedative
6.3.2. Antitoxic (Off-label use)
6.4. Global Atipamezole Market Attractiveness, by Application
7. Global Atipamezole Market Analysis and Forecast, by Route of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Atipamezole Market Value Forecast, by Route of Administration, 2018–2030
7.3.1. Intramuscular
7.3.2. Intravenous
7.3.3. Others
7.4. Global Atipamezole Market Attractiveness, by Route of Administration
8. Global Atipamezole Market Analysis and Forecast, by Animal Type
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Atipamezole Market Value Forecast, by Animal Type, 2018–2030
8.3.1. Dogs
8.3.2. Cats
8.3.3. Others
8.4. Global Atipamezole Market Attractiveness, by Animal Type
9. Global Atipamezole Market Analysis and Forecast, by Distribution Channel
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Global Atipamezole Market Value Forecast, by Distribution Channel, 2018–2030
9.3.1. Veterinary Hospitals
9.3.2. Retail Pharmacies
9.3.3. Online Pharmacies
9.4. Global Atipamezole Market Attractiveness, by Distribution Channel
10. Global Atipamezole Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Atipamezole Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global Atipamezole Market Attractiveness, by Country/Region
11. North America Atipamezole Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. North America Atipamezole Market Value Forecast, by Application, 2018–2030
11.2.1. Anti-sedative
11.2.2. Antitoxic (Off-label use)
11.3. North America Atipamezole Market Value Forecast, by Route of Administration, 2018–2030
11.3.1. Intramuscular
11.3.2. Intravenous
11.3.3. Others
11.4. North America Atipamezole Market Value Forecast, by Animal Type, 2018–2030
11.4.1. Dogs
11.4.2. Cats
11.4.3. Others
11.5. North America Atipamezole Market Value Forecast, by Distribution Channel, 2018–2030
11.5.1. Veterinary Hospitals
11.5.2. Retail Pharmacies
11.5.3. Online Pharmacies
11.6. North America Atipamezole Market Value Forecast, by Country, 2018–2030
11.6.1. U.S.
11.6.2. Canada
11.7. North America Atipamezole Market Attractiveness Analysis
11.7.1. By Application
11.7.2. By Route of Administration
11.7.3. By Animal Type
11.7.4. By Distribution Channel
11.7.5. By Country
12. Europe Atipamezole Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Europe Atipamezole Market Value Forecast, by Application, 2018–2030
12.2.1. Anti-sedative
12.2.2. Antitoxic (Off-label use)
12.3. Europe Atipamezole Market Value Forecast, by Route of Administration, 2018–2030
12.3.1. Intramuscular
12.3.2. Intravenous
12.3.3. Others
12.4. Europe Atipamezole Market Value Forecast, by Animal Type, 2018–2030
12.4.1. Dogs
12.4.2. Cats
12.4.3. Others
12.5. Europe Atipamezole Market Value Forecast, by Distribution Channel, 2018–2030
12.5.1. Veterinary Hospitals
12.5.2. Retail Pharmacies
12.5.3. Online Pharmacies
12.6. Europe Atipamezole Market Value Forecast, by Country/Sub-region, 2018–2030
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Atipamezole Market Attractiveness Analysis
12.7.1. By Application
12.7.2. By Route of Administration
12.7.3. By Animal Type
12.7.4. By Distribution Channel
12.7.5. By Country/Sub-region
13. Asia Pacific Atipamezole Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Asia Pacific Atipamezole Market Value Forecast, by Application, 2018–2030
13.2.1. Anti-sedative
13.2.2. Antitoxic (Off-label use)
13.3. Asia Pacific Atipamezole Market Value Forecast, by Route of Administration, 2018–2030
13.3.1. Intramuscular
13.3.2. Intravenous
13.3.3. Others
13.4. Asia Pacific Atipamezole Market Value Forecast, by Animal Type, 2018–2030
13.4.1. Dogs
13.4.2. Cats
13.4.3. Others
13.5. Asia Pacific Atipamezole Market Value Forecast, by Distribution Channel, 2018–2030
13.5.1. Veterinary Hospitals
13.5.2. Retail Pharmacies
13.5.3. Online Pharmacies
13.6. Asia Pacific Atipamezole Market Value Forecast, by Country/Sub-region, 2018–2030
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific Atipamezole Market Attractiveness Analysis
13.7.1. By Application
13.7.2. By Route of Administration
13.7.3. By Animal Type
13.7.4. By Distribution Channel
13.7.5. By Country/Sub-region
14. Latin America Atipamezole Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Latin America Atipamezole Market Value Forecast, by Application, 2018–2030
14.2.1. Anti-sedative
14.2.2. Antitoxic (Off-label use)
14.3. Latin America Atipamezole Market Value Forecast, by Route of Administration, 2018–2030
14.3.1. Intramuscular
14.3.2. Intravenous
14.3.3. Others
14.4. Latin America Atipamezole Market Value Forecast, by Animal Type, 2018–2030
14.4.1. Dogs
14.4.2. Cats
14.4.3. Others
14.5. Latin America Atipamezole Market Value Forecast, by Distribution Channel, 2018–2030
14.5.1. Veterinary Hospitals
14.5.2. Retail Pharmacies
14.5.3. Online Pharmacies
14.6. Latin America Atipamezole Market Value Forecast, by Country/Sub-region, 2018–2030
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America Atipamezole Market Attractiveness Analysis
14.7.1. By Application
14.7.2. By Route of Administration
14.7.3. By Animal Type
14.7.4. By Distribution Channel
14.7.5. By Country/Sub-region
15. Middle East & Africa Atipamezole Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Middle East & Africa Atipamezole Market Value Forecast, by Application, 2018–2030
15.2.1. Anti-sedative
15.2.2. Antitoxic (Off-label use)
15.3. Middle East & Africa Atipamezole Market Value Forecast, by Route of Administration, 2018–2030
15.3.1. Intramuscular
15.3.2. Intravenous
15.3.3. Others
15.4. Middle East & Africa Atipamezole Market Value Forecast, by Animal Type, 2018–2030
15.4.1. Dogs
15.4.2. Cats
15.4.3. Others
15.5. Middle East & Africa Atipamezole Market Value Forecast, by Distribution Channel, 2018–2030
15.5.1. Veterinary Hospitals
15.5.2. Retail Pharmacies
15.5.3. Online Pharmacies
15.6. Middle East & Africa Atipamezole Market Value Forecast, by Country/Sub-region, 2018–2030
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa Atipamezole Market Attractiveness Analysis
15.7.1. By Application
15.7.2. By Route of Administration
15.7.3. By Animal Type
15.7.4. By Distribution Channel
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (by Tier and Size of companies)
16.2. Market Share Analysis/Ranking by Company (2019)
16.3. Company Profiles
16.3.1. Zoetis Services LLC
16.3.1.1. Company Overview
16.3.1.2. Company Financials
16.3.1.3. Growth Strategies
16.3.1.4. SWOT Analysis
16.3.2. Merck & Co., Inc. (Merck Sharp & Dohme Corp)
16.3.2.1. Company Overview
16.3.2.2. Company Financials
16.3.2.3. Growth Strategies
16.3.2.4. SWOT Analysis
16.3.3. Modern Veterinary Therapeutics
16.3.3.1. Company Overview
16.3.3.2. Growth Strategies
16.3.3.3. SWOT Analysis
16.3.4. Orion Corporation
16.3.4.1. Company Overview
16.3.4.2. Company Financials
16.3.4.3. Growth Strategies
16.3.4.4. SWOT Analysis
16.3.5. Jurox Pty Limited
16.3.5.1. Company Overview
16.3.5.2. Growth Strategies
16.3.5.3. SWOT Analysis
16.3.6. Vetoquinol UK Limited
16.3.6.1. Company Overview
16.3.6.2. Company Financials
16.3.6.3. Growth Strategies
16.3.6.4. SWOT Analysis
16.3.7. Chanelle Pharma Group
16.3.7.1. Company Overview
16.3.7.2. Growth Strategies
16.3.7.3. SWOT Analysis
16.3.8. Forte Healthcare Ltd
16.3.8.1. Company Overview
16.3.8.2. Growth Strategies
16.3.8.3. SWOT Analysis
16.3.9. Troy Laboratories Pty Ltd
16.3.9.1. Company Overview
16.3.9.2. Growth Strategies
16.3.9.3. SWOT Analysis
List of TablesTable 01: Global Atipamezole Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 02: Global Atipamezole Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 03: Global Atipamezole Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
Table 04: Global Atipamezole Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 05: Global Atipamezole Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 06: North America Atipamezole Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 07: North America Atipamezole Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 08: North America Atipamezole Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 09: North America Atipamezole Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
Table 10: North America Atipamezole Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 11: Europe Atipamezole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 12: Europe Atipamezole Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 13: Europe Atipamezole Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 14: Europe Atipamezole Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
Table 15: Europe Atipamezole Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 16: Asia Pacific Atipamezole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 17: Asia Pacific Atipamezole Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 18: Asia Pacific Atipamezole Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 19: Asia Pacific Atipamezole Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
Table 20: Asia Pacific Atipamezole Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 21: Latin America Atipamezole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 22: Latin America Atipamezole Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 23: Latin America Atipamezole Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 24: Latin America Atipamezole Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
Table 25: Latin America Atipamezole Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 26: Middle East & Africa Atipamezole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 27: Middle East & Africa Atipamezole Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 28: Middle East & Africa Atipamezole Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 29: Middle East & Africa Atipamezole Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
Table 30: Middle East & Africa Atipamezole Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030